These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22993376)

  • 1. Gemcitabine-induced pulmonary toxicity.
    Chi DC; Brogan F; Turenne I; Zelonis S; Schwartz L; Saif MW
    Anticancer Res; 2012 Sep; 32(9):4147-9. PubMed ID: 22993376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
    Shaib W; Lansigan F; Cornfeld D; Syrigos K; Saif MW
    JOP; 2008 Nov; 9(6):708-14. PubMed ID: 18981552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
    Hiraya D; Kagohashi K; Sakamoto N; Kondo T; Satoh H
    JOP; 2010 Mar; 11(2):186-8. PubMed ID: 20208333
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report.
    Fenocchio E; Depetris I; Campanella D; Garetto L; Schianca FC; Galizia D; Grignani G; Aglietta M; Leone F
    BMC Cancer; 2016 Oct; 16(1):793. PubMed ID: 27733144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.
    Tamiya A; Endo M; Shukuya T; Igawa S; Tsuya A; Nakamura Y; Murakami H; Takahashi T; Boku N; Yamamoto N
    Pancreas; 2009 Oct; 38(7):838-40. PubMed ID: 19893461
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemcitabine pulmonary toxicity in ovarian cancer.
    Ko E; Lee S; Goodman A
    Oncologist; 2008 Jul; 13(7):807-11. PubMed ID: 18614588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute lung injury induced by gemcitabine.
    Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
    Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
    Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of drug induced interstitial pneumonitis after gemcitabine treatment for pancreatic carcinoma].
    Ishibashi Y; Ito Y
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):651-3. PubMed ID: 19381041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
    Biswas S; Nik S; Corrie PG
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy.
    Yakabe T; Kitahara K; Komiya K; Sueoka-Aragane N; Kimura S; Sugioka T; Noshiro H
    World J Surg Oncol; 2013 Jul; 11():167. PubMed ID: 23883337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of drug-induced interstitial pneumonitis after gemcitabine treatment for advanced pancreatic cancer].
    Nomura M; Inoue Y; Fujita S; Sakao J; Hirota M; Souda S
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):123-7. PubMed ID: 16410712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-induced severe pulmonary toxicity.
    Barlési F; Villani P; Doddoli C; Gimenez C; Kleisbauer JP
    Fundam Clin Pharmacol; 2004 Feb; 18(1):85-91. PubMed ID: 14748759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BOOP as a rare complication of gemcitabine therapy.
    Kawsar HI; Spiro TP; Cocco A; Daw HA
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gemcitabine in cancer therapy.
    Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
    Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-related radiation recall in a patient with pancreatic cancer.
    Saif MW; Sellers S; Russo S
    Anticancer Drugs; 2006 Jan; 17(1):107-11. PubMed ID: 16317298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.